ArticleAntimicrobial agents and chemotherapy2011

Zanamivir, at 600 milligrams twice daily, inhibits oseltamivir-resistant 2009 pandemic H1N1 influenza virus in an in vitro hollow-fiber infection model system.

Ashley N Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.